Cirrhosis of the liver is a condition in which the liver is scarred and damaged research hub

A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Combination Compared to Zibotentan Monotherapy as well as Zibotentan/Dapagliflozin and Zibotentan Monotherapy Compared to Placebo in Participants with Cirrhosis

This study is looking at how safe new drug combinations (Zibotentan with Dapagliflozin, or Zibotentan on its own) are for people with liver scarring (cirrhosis). Researchers want to see if these treatments help manage fluid build-up in the body, compared to a dummy pill.